Depression Still Requires Novel Psychiatric Medication
Abstract
No Abstract
1. Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007;41(3-4):189-206.
2. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7(2):137-151.
3. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Intern Med 2011;155:772-785.
4. Lee G, Bae H. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression. Biomed Res Int 2017; 2017: 6596241.
2. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006;7(2):137-151.
3. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Intern Med 2011;155:772-785.
4. Lee G, Bae H. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression. Biomed Res Int 2017; 2017: 6596241.
Files | ||
Issue | Vol 6, No1-2 (Winter 2018) | |
Section | Editorial | |
Keywords | ||
Depression |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Kowsar M, Mirzaei M. Depression Still Requires Novel Psychiatric Medication. J Pharm Care. 2018;6(1-2):1-2.